Ageing nuclear assets don't have to mean higher maintenance costs. Discover how HVTS® cladding helps extend the life of PWR secondary system components, reduce outage duration, support ALARA principles, and protect against FAC, erosion-corrosion and other degradation mechanisms. Learn more.
Recent happenings in Europe highlight that nuclear power activities are expanding globally. Here is a roundup of headlines with an international flavor.
Framatome announced this week that its nuclear fuel manufacturing facility in Richland, Wash., has received Nuclear Regulatory Commission approval for a license amendment supporting fabrication of nuclear fuel with enrichment levels above 5 percent uranium-235, with manufacturing scheduled to begin in 2027.
France’s state-owned electric utility EDF has announced that Flamanville-3—the country’s first EPR—reached full nuclear thermal power for the first time, generating 1,669 megawatts of gross electrical power. This major milestone is significant in terms of both this project and France’s broader nuclear sector.
Mike Harkin
When ANS first announced its new Nuclear 101 certificate course, I was excited. This felt like a course tailor-made for me, a transplant into the commercial nuclear world. I enrolled for the inaugural session held in November 2024, knowing it was going to be hard (this is nuclear power, of course)—but I had been working on ramping up my knowledge base for the past year, through both my employer and at a local college.
The course was a fast-and-furious roller-coaster ride through all the key components of the nuclear power industry, in one highly challenging week. In fact, the challenges the students experienced caught even the instructors by surprise. Thankfully, the shared intellectual stretch we students all felt helped us band together to push through to the end.
We were all impressed with the quality of the instructors, who are some of the top experts in the field. We appreciated not only their knowledge base but their support whenever someone struggled to understand a concept.
Framatome announced that it has inaugurated a new workshop dedicated to the fabrication of fuel for research reactors and targets for medical isotopes at the company’s Romans-sur-Isère site in France. The workshops are part of Framatome’s CERCA division, which manufactures fuel and irradiation targets for research reactors.
Southern Nuclear recently loaded nuclear fuel with uranium-235 enriched up to 6 percent—higher than the usual 3–5 percent enrichment—into Vogtle-2 to test it through irradiation.
French nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the industrial-scale production of the alpha-emitting medical radioisotope astatine-211 across Europe and the United States.
Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.
Framatome’s enhanced accident tolerant fuel assemblies recently completed a third 18-month fuel cycle at Southern Nuclear’s Vogtle-2 plant—the first of this type of fuel to reach this milestone in the U.S., the company said.
A hybrid public meeting hosted by the Nuclear Regulatory Commission on October 30 will feature chair Christopher Hanson and commissioners David Wright, Annie Caputo, and Bradley Crowell.
The Department of Energy announced contracts yesterday for six companies to perform high-assay low-enriched uranium (HALEU) deconversion and to transform enriched uranium hexafluoride (UF6) to other chemical forms, including metal or oxide, for storage before it is fabricated into fuel for advanced reactors. It amounts to a first round of contracting. “These contracts will allow selected companies to bid on work for deconversion services,” according to the DOE’s announcement, “creating strong competition and allowing DOE to select the best fit for future work.”
TerraPower announced May 29 that it will work with Framatome North America to fund the high-assay low-enriched uranium (HALEU) metallization pilot plant that Framatome is building at its fuel fabrication facility in Richland, Wash. A successful demonstration of Framatome’s capability of converting enriched uranium oxide to HALEU metal will “support the development of the domestic HALEU supply chain,” both companies say.
Framatome was recently awarded a multimillion-dollar contract to perform mitigation of buried condenser feed pipes at a three-unit nuclear power plant in the United States.
The France-based nuclear company plans to install spray-in-place structural pipe liner to mitigate more than one mile of large diameter underground piping connected to plant condenser boxes. The project will be performed during nine outages over eight years, with the first application planned for fall 2025.
An official groundbreaking last week at Framatome’s Mill Ridge Road facility, in Lynchburg, Va., marks the start of a $50 million expansion and an eventual addition of 500 employees, according to the nuclear company.
Bulgarian officials have approved the transition to Westinghouse fuel at the nation's Kozloduy nuclear power plant, as Bulgaria moves away from its reliance on Russian supplies. The fuel was recently delivered for use in Unit 5.
Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at KHNP’s Wolsong nuclear power plant in South Korea. The companies also will investigate the feasibility of using the plant to support Korean production of medical radioisotopes in the future.
French nuclear developer Framatome is slated to deliver key equipment for Sizewell C Ltd.’s two large reactors planned for the United Kingdom’s Suffolk coast.
The agreement, reportedly worth multiple billions of euros, was announced this week and will involve Framatome from the design phase until commissioning. The company also agreed to a long-term fuel supply deal. Framatome is 80.5 percent owned by France’s EDF and 19.5 percent owned by Mitsubishi Heavy Industries.
Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177. The cooperative agreement was signed during the World Nuclear Exhibition 2023, held November 28–30 in Paris.
Framatome Inc. and Ultra Safe Nuclear Corp. (USNC) signed an agreement on November 28 at the World Nuclear Exhibition in Paris, France, establishing a joint venture to manufacture nuclear fuel for USNC’s gas-cooled microreactor and other advanced reactor designs. Working together, the companies plan to produce commercial quantities of TRISO fuel particles and USNC’s proprietary Fully Ceramic Microencapsulated (FCM) fuel, which contains TRISO fuel particles within a ceramic fuel pellet.
France-based Framatome and the Hungary’s Ministry of Energy agreed this week to strengthen their relationship in the field of nuclear energy, including in such areas as fuel supply, education, research and development, implementation of new technologies, and long-term operation.